TGFB1 and inflammatory bowel disease: In 2016, Jiang et al. demonstrated that immunosuppressive EVs with high levels of TGF-β1 are produced by IECs, and the intravenous injection of these EVs into DSS-induced IBD mice decreases IBD severity by inducing regulatory T cells and immunosuppressive DCs.